Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

SBTX

Silverback Therapeutics (SBTX)

Silverback Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SBTX
FechaHoraFuenteTítuloSímboloCompañía
28/06/202315:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBTXSilverback Therapeutics Inc
15/05/202308:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SBTXSilverback Therapeutics Inc
08/05/202315:35Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:SBTXSilverback Therapeutics Inc
01/05/202315:42Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SBTXSilverback Therapeutics Inc
01/05/202315:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SBTXSilverback Therapeutics Inc
23/03/202315:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SBTXSilverback Therapeutics Inc
23/02/202315:01GlobeNewswire Inc.ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle InjectorsNASDAQ:SBTXSilverback Therapeutics Inc
22/02/202315:05GlobeNewswire Inc.ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including AnaphylaxisNASDAQ:SBTXSilverback Therapeutics Inc
13/02/202315:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SBTXSilverback Therapeutics Inc
09/02/202305:30GlobeNewswire Inc.ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023NASDAQ:SBTXSilverback Therapeutics Inc
17/01/202316:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SBTXSilverback Therapeutics Inc
17/01/202315:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SBTXSilverback Therapeutics Inc
05/01/202316:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBTXSilverback Therapeutics Inc
30/11/202215:24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SBTXSilverback Therapeutics Inc
21/11/202215:08Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:SBTXSilverback Therapeutics Inc
10/11/202216:02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SBTXSilverback Therapeutics Inc
10/11/202207:00GlobeNewswire Inc.ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including AnaphylaxisNASDAQ:SBTXSilverback Therapeutics Inc
08/11/202215:02GlobeNewswire Inc.ARS Pharmaceuticals Closes Merger with Silverback TherapeuticsNASDAQ:SBTXSilverback Therapeutics Inc
27/10/202215:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SBTXSilverback Therapeutics Inc
21/10/202207:36Dow Jones NewsSilverback Therapeutics' Nasal Spray for Allergic Reactions Gets FDA Review ApprovalNASDAQ:SBTXSilverback Therapeutics Inc
21/10/202206:31Business WireSilverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including AnaphylaxisNASDAQ:SBTXSilverback Therapeutics Inc
06/10/202215:17Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SBTXSilverback Therapeutics Inc
11/08/202216:23Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:SBTXSilverback Therapeutics Inc
22/07/202205:15TipRanksAnalysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV), Anixa Biosciences (ANIX) and Silverback Therapeutics (SBTX)NASDAQ:SBTXSilverback Therapeutics Inc
21/07/202215:00Business WireSilverback Therapeutics and ARS Pharmaceuticals Announce MergerNASDAQ:SBTXSilverback Therapeutics Inc
18/07/202205:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SBTXSilverback Therapeutics Inc
17/05/202215:05Business WireSilverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:SBTXSilverback Therapeutics Inc
15/05/202211:38TipRanksJonesTrading Keeps Their Hold Rating on Silverback Therapeutics (SBTX)NASDAQ:SBTXSilverback Therapeutics Inc
13/05/202207:49TipRanksH.C. Wainwright Keeps a Hold Rating on Silverback Therapeutics (SBTX)NASDAQ:SBTXSilverback Therapeutics Inc
12/05/202215:01Business WireSilverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:SBTXSilverback Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SBTX